The Royal College of Pathologists · Verified against the College's 2026 general examination regulations, issued December 2025, and currently linked 2026 specialty regulations. The workbook label 'Fellowship of the Royal College of Pathologists (FRCPath)' names the Fellowship qualification; it maps to the College's specialty-specific Fellowship examination, comprising Parts 1 and 2. No specialty or examination part was assigned. This material therefore provides an explicitly limited cross-specialty preview using verified histopathology, haematology, clinical biochemistry, infection, and immunology/allergy outlines. It is not a combined official syllabus, a specialty mock examination, or a replacement credential.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• Regulations, Guidelines and Policies
• Regulations, Guidelines and Policies Documents
• Fellowship, Diploma and Certificate examinations: regulations and guidelines for 2026
• Histopathology examination regulations 2026
• Haematology examination regulations 2026
• Clinical biochemistry examination regulations 2026
• Clinical Biochemistry
• FRCPath Part 1 and Combined Infection Certificate Examination (CICE) regulations 2026
• Infection
• Immunology and allergy examination regulations 2026
• HER2 Testing in Breast Cancer – 2023 Guideline Update
• HER2 Breast Cancer Testing Guideline Update: Summary of Recommendations
• Colon and Rectum Biomarker Reporting, version 1.3.0.0
• Invasive Melanoma of the Skin: Biopsy, version 1.1.0.0
• Tumor Grade
• Cancer Staging
• Prolonged Clotting Time Evaluation
• Thalassemias
• Thrombotic Microangiopathies – Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome
• Management of suspected reactions
• Hemolytic Anemias
• Hypercalcemia and Hypocalcemia – Vitamin D Testing
• Analytical Considerations in the Evaluation of Thyroid Function
• Hypothyroidism
• Laboratory Quality Management System Training Toolkit: Quantitative QC, Module 7
• Laboratory Quality Management System Training Toolkit: External Quality Assessment, Module 10
• Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests
• Clinical Testing and Diagnosis for Hepatitis B
• Clinical Testing and Diagnosis for Tuberculosis
• Definitions of S, I and R
• Clinical Testing and Diagnosis for C. diff Infection
• Clinical Diagnosis and Testing: Alpha-gal Syndrome
• Complement Testing – Complement Deficiency and Anticomplement Therapeutic Response Monitoring
• Celiac Disease
• Allergy Blood Test
• pdf-1863.pdf
• Meeting the Biotin Challenge | myadlm.org
• PID-Nov-2015.pdf
• g089-guidance-on-reporting-of-thyroid-cytology-specimens.pdf
• Frozen Section (Fresh Tissue) - Northern Region Pathology Network Test Guide
• Acute Myeloid Leukemia Treatment (PDQ®) - NCI
• SanzMAetal2019_Blood.Managementofacutepromyelocyticleukemia-updatedrecommendationsfromanexpertpaneloftheEuropeanLeukemiaNet.pdf
• IMWG Criteria for the Diagnosis of MM | Inl Myeloma Fn
• Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®) - NCI
• European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021) - PMC
• phpt_concise_summary_final_020322.pdf
• AACC Guidance Document on Biotin Interference in Laboratory Tests | myadlm.org
• Diagnostic%20Algorithm%20for%20Food%20Allergy.pdf